BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37627140)

  • 1. Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).
    Abruzzese E; Bocchia M; Trawinska MM; Raspadori D; Bondanini F; Sicuranza A; Pacelli P; Re F; Cavalleri A; Farina M; Malagola M; Russo D; De Fabritiis P; Bernardi S
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation.
    Bernardi S; Malagola M; Zanaglio C; Polverelli N; Dereli Eke E; D'Adda M; Farina M; Bucelli C; Scaffidi L; Toffoletti E; Deambrogi C; Stagno F; Bergamaschi M; Franceschini L; Abruzzese E; Divona MD; Gobbi M; Di Raimondo F; Gaidano G; Tiribelli M; Bonifacio M; Cattaneo C; Iurlo A; Russo D
    Cancer Med; 2019 May; 8(5):2041-2055. PubMed ID: 30950237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual Peripheral Blood CD26
    Bocchia M; Sicuranza A; Abruzzese E; Iurlo A; Sirianni S; Gozzini A; Galimberti S; Aprile L; Martino B; Pregno P; Sorà F; Alunni G; Fava C; Castagnetti F; Puccetti L; Breccia M; Cattaneo D; Defina M; Mulas O; Baratè C; Caocci G; Sica S; Gozzetti A; Luciano L; Crugnola M; Annunziata M; Tiribelli M; Pacelli P; Ferrigno I; Usala E; Sgherza N; Rosti G; Bosi A; Raspadori D
    Front Oncol; 2018; 8():194. PubMed ID: 29900128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26
    Pacelli P; Santoni A; Sicuranza A; Abruzzese E; Giai V; Crugnola M; Annunziata M; Galimberti S; Iurlo A; Luciano L; Sorà F; Fava C; Bestoso E; Marzano C; Cartocci A; Defina M; Sammartano V; Cencini E; Raspadori D; Bocchia M
    Front Pharmacol; 2023; 14():1194712. PubMed ID: 37305536
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukemic stem cells shall be searched in the bone marrow before "tyrosine kinase inhibitor-discontinuation" in chronic myeloid leukemia.
    Ilhan O; Narli Ozdemir Z; Dalva K; Arslan A; Okay Ozgeyik M; Ipek S; Saydam G; Haznedaroglu IC
    Int J Lab Hematol; 2021 Oct; 43(5):1110-1116. PubMed ID: 33834631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.
    Alikian M; Gale RP; Apperley JF; Foroni L
    Biomol Detect Quantif; 2017 Mar; 11():4-20. PubMed ID: 28331814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNome profiling of LSC-enriched CD34
    Ruiz MS; Sánchez MB; Bonecker S; Furtado C; Koile D; Yankilevich P; Cranco S; Custidiano MDR; Freitas J; Moiraghi B; Pérez MA; Pavlovsky C; Varela AI; Ventriglia V; Sánchez Ávalos JC; Larripa I; Zalcberg I; Mordoh J; Valent P; Bianchini M
    Front Pharmacol; 2020; 11():612573. PubMed ID: 33569005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia.
    Sharma P; Sachdeva MUS; Naseem S; Sreedharanunni S; Das R; Malhotra P; Varma N
    Int J Lab Hematol; 2022 Jun; 44(3):518-523. PubMed ID: 35142061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M; Whale AS; Akiki S; Piechocki K; Torrado C; Myint T; Cowen S; Griffiths M; Reid AG; Apperley J; White H; Huggett JF; Foroni L
    Clin Chem; 2017 Feb; 63(2):525-531. PubMed ID: 27979961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages of digital PCR in the detection of low abundance
    Yan Z; Sun Q; Zhang H; Han Y; Qiao J; Niu M; Zhu S; Zhao K; Wu Q; Cheng H; Cao J; Zeng L; Li Z; Xu K
    Oncol Lett; 2019 Nov; 18(5):5139-5144. PubMed ID: 31612025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow Cytometry Assessment of CD26
    Raspadori D; Pacelli P; Sicuranza A; Abruzzese E; Iurlo A; Cattaneo D; Gozzini A; Galimberti S; Baratè C; Pregno P; Nicolosi M; Sorà F; Annunziata M; Luciano L; Caocci G; Moretti S; Sgherza N; Fozza C; Russo S; Usala E; Liberati MA; Ciofini S; Trawinska MM; Gozzetti A; Bocchia M
    Cytometry B Clin Cytom; 2019 Jul; 96(4):294-299. PubMed ID: 30714299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.
    Herrmann H; Sadovnik I; Cerny-Reiterer S; Rülicke T; Stefanzl G; Willmann M; Hoermann G; Bilban M; Blatt K; Herndlhofer S; Mayerhofer M; Streubel B; Sperr WR; Holyoake TL; Mannhalter C; Valent P
    Blood; 2014 Jun; 123(25):3951-62. PubMed ID: 24778155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of tyrosine kinase inhibitors based on
    Kim Y; Kim S; Lee JM; Ahn A; Yoo JW; Lee JW; Cho B; Chung NG; Kim Y; Kim M
    Front Pediatr; 2022; 10():928136. PubMed ID: 35967571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia.
    Ebian HF; Abdelnabi AM; Abdelazem AS; Khamis T; Fawzy HM; Hussein S
    Leuk Res Rep; 2022; 17():100321. PubMed ID: 35602932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation.
    Chomel JC; Bonnet ML; Sorel N; Sloma I; Bennaceur-Griscelli A; Rea D; Legros L; Marfaing-Koka A; Bourhis JH; Ame S; Guerci-Bresler A; Rousselot P; Turhan AG
    Oncotarget; 2016 Jun; 7(23):35293-301. PubMed ID: 27167108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD26/DPP-4 in Chronic Myeloid Leukemia.
    Sicuranza A; Raspadori D; Bocchia M
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital PCR can provide improved
    Smitalova D; Dvorakova D; Racil Z; Romzova M
    Pract Lab Med; 2021 May; 25():e00210. PubMed ID: 33778144
    [No Abstract]   [Full Text] [Related]  

  • 18. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
    Wang WJ; Zheng CF; Liu Z; Tan YH; Chen XH; Zhao BL; Li GX; Xu ZF; Ren FG; Zhang YF; Chang JM; Wang HW
    Eur J Haematol; 2018 Sep; 101(3):291-296. PubMed ID: 29691899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital PCR for
    Kockerols CCB; Valk PJM; Levin MD; Pallisgaard N; Cornelissen JJ; Westerweel PE
    Hemasphere; 2020 Dec; 4(6):e496. PubMed ID: 33283168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients?
    Zanaglio C; Bernardi S; Gandolfi L; Farina M; Re F; Polverelli N; Zollner T; Turra A; Morello E; Malagola M; Russo D
    Case Rep Oncol; 2020; 13(3):1263-1269. PubMed ID: 33250741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.